RxDoctor Payments Data

Steven Sanderson, MD

Family Medicine · Hickory, NCNPI 1508881681

Payments from drug & device makers

$3,732in general payments, 2019–2025

Across 213 payments — averaging $17.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$556
  • Novo Nordisk$504
  • AbbVie$317
  • AstraZeneca$305
  • Lilly USA, LLC$251
  • GSK$242
  • plus $2K from 34 others

What the payments were for

  • Food & beverage$3,732100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,732 in reported general payments places this provider in the 85th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$175,563
Medicare patients
229
Services billed
3,408

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban99$74,708
TrulicityDulaglutide63$64,846
JardianceEmpagliflozin58$62,347
OzempicSemaglutide40$57,463
MounjaroTirzepatide20$27,512
XareltoRivaroxaban28$18,521
Tresiba Flextouch U-100Insulin Degludec25$10,935
Spiriva HandihalerTiotropium Bromide21$10,812
Breo ElliptaFluticasone/Vilanterol12$10,133
MyrbetriqMirabegron11$7,798
Combivent RespimatIpratropium/Albuterol Sulfate14$6,978
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$6,850
SymbicortBudesonide/Formoterol Fumarate15$4,804
Esomeprazole Magnesium64$4,441
Novolog FlexpenInsulin Aspart16$4,065

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro, Humulin 70-30$251$94,65398 claims
PfizerEliquis, Paxlovid$556$76,137119 claims
Boehringer IngelheimJardiance, Combivent Respimat$74$69,32572 claims
Novo NordiskOzempic$504$57,46340 claims
Johnson & JohnsonXarelto$93$18,52128 claims
AstraZenecaBreztri Aerosphere, Symbicort$305$11,65426 claims
GSKBreo Ellipta$242$10,13312 claims
Astellas Pharma US IncMyrbetriq$64$7,79811 claims
AbbVieSynthroid$317$2,73736 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Hickory

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →